Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Choosing the right retirement account at 30 can be challenging. Learn about the different options available to make the best choice for your future.
22,749 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
A major fund reshaped its Workiva stake in a recent SEC filing, signaling routine portfolio rebalancing rather than a...
SoFi has surprised some investors by turning a key profitability metric into a clear strength. This article breaks do...
With signs that the Iran conflict is cooling, markets eye how oil, spreads, and Central Bank policy could reshape mor...
Rent prices dropping nationwide are reshaping tenant leverage as supply catches up with demand. This report flags whe...
GM authorized a $6 billion buyback and boosted its dividend, signaling a shift toward disciplined cash returns. Ford,...
Salesforce stock has faced renewed pressure as growth slows and concerns about AI monetization persist. This pragmati...
A simple idea, a tight framework, and a disciplined plan can turn a small $8 stock into meaningful wealth—without cha...
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
In May, iren limited rallied almost 40% as investors priced in AI growth, earnings signals, and a new Nvidia partners...
Earnings season often brings volatility, but a post-earnings sell-off could incredible offer a rare entry point for p...